Edition:
United States

Chiasma Inc (CHMA.OQ)

CHMA.OQ on NASDAQ Stock Exchange Global Select Market

3.30USD
21 Sep 2018
Change (% chg)

$0.15 (+4.76%)
Prev Close
$3.15
Open
$3.15
Day's High
$3.30
Day's Low
$3.05
Volume
124,160
Avg. Vol
12,060
52-wk High
$3.30
52-wk Low
$1.20

Select another date:

Mon, May 14 2018

BRIEF-Chiasma Announces FDA Agreement To Redefine Certain Secondary Endpoints In Phase 3 Clinical Trial

* CHIASMA ANNOUNCES FDA AGREEMENT TO REDEFINE CERTAIN SECONDARY ENDPOINTS IN CHIASMA OPTIMAL PHASE 3 CLINICAL TRIAL

BRIEF-Chiasma Reports Q1 Loss Per Share $0.29

* CHIASMA - EXPECTS EXISTING CASH, INVESTMENTS WILL BE SUFFICIENT TO FUND OPERATIONS THROUGH ANTICIPATED RELEASE OF DATA FROM CHIASMA OPTIMAL TRIAL BY 2019 END Source text for Eikon: Further company coverage:

Select another date: